Coronavirus 229E

Coronavirus NL63

Coronavirus HKU1

Bordetella pertussis


Clostridium Difficle toxin A/B

 Plesiomonas shigelloides


Yersinia enterocolitica


GPP is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and identification of multiple viral, parasitic, and bacterial nucleic acids in human stool specimens from individuals with signs and symptoms of infectious colitis or gastroenteritis.

Many pathogens, including bacteria, parasites, and viruses can cause infectious diarrhea. Previously, many of the pathogens responsible could only be isolated using traditional techniques such as stool culture or ova and parasite exam that were often time consuming and lacked sensitivity. To improve the detection of intestinal pathogens,  our laboratory provides Multiplexed PCR, FDA-cleared testing with an overall sensitivity and specificity of 98.5% and 99.3%, respectively.  Rapid and accurate diagnostic testing for gastrointestinal pathogens may help identify which patients to isolate or cohort faster and determine if antibiotic therapy is appropriate. The misdiagnosis and mistreatment of GI infections can have serious clinical implications. Incorrect diagnosis and treatment translate into an increased risk of morbidity and mortality, particularly for patients at risk, such as infants, the elderly, and immunocompromised patients.The administration of inappropriate antibiotic therapy increases patient susceptibility to super infections. Antibiotic misuse also contributes to the risk of developing antibiotic resistance, an increasing public health concern recently identified by the WHO as a global health security threat.

​Influenza B

Human Metapneumovirus

Human Rhinovirus/Enterovirus

Influenza AH1

Mycoplasma pneumoniae

Respiratory Pathogen Panel

Determining the microbial cause of an infectious disease has been described by the Institute of Medicine as the cornerstone of effective disease control and prevention. A fast diagnosis can ensure that proper treatment is administered in a timely manner. Delayed treatment of upper respiratory infections can increase the risk of progression to the lower respiratory tract and development of pneumonia, whereas early use of antivirals has been associated with more rapid viral clearance, reduced symptoms, reduced progression to pneumonia, and reduced mortality. By reducing the use of antibiotics, accurate diagnoses can help decrease the rate of antibiotic resistance.

A proper diagnosis yields many patient and physician benefits, such as; 

  • • Facilitating timely and effective treatment 
  • • Preventing the secondary spread of infection 
  • • Preventing the use of unnecessary antibiotics 
  • • Reducing the costs of unnecessary tests 

Results available within 2 hours


Enteroxigenic E. Coli LT/ST

Enteroaggregative E. coli

Enteropathogenic E. coli 

Shiga-like toxin-producing E. coli 

E. coli O157 

Shigella/Enteroinvasive E. coli ​





Entamoeba histolytica

Giardia lamblia​

Parainfluenza  (PIV 1)

Parainfluenza  (PIV 2)

Parainfluenza (PIV 3)

Parainfluenza 1 (PIV 4)

Respiratory Syncytial Virus

Gastrointestinal Pathogen Panel

​Influenza A

Influenza AH3

Influenza AH1 2009

Coronavirus OC43

Chlamydophilia pneumoniae

Simultaneously detect and identify multiple bacterial, viral, and parasitic pathogens in a single test, with results available the same day.  

GeneX Laboratory PC Molecular Genetics & Diagnostics

​Adenovirus F40/41


Norovirus GI/GII

Rotavirus A

Sapovirus (I, II, IV and V)

Call Us:  +1 (949)-527-6517

GeneX Services